CC312 trials for Lupus

All CC312 trials · All Lupus trials

Phase breakdown

Recruiting trials studying CC312 for Lupus

• A Study of CC312 for Relapsed/Refractory Autoimmune Diseases
  NCT07193810 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Safety Study of CC312 in Autoimmune Disease Patients
  NCT06888960 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Efficacy Study of CC312 for Moderate to Severe SLE
  NCT07177911 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study CC312 for Lupus?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.